Financings in Brief: Ventana Medical Systems
This article was originally published in The Gray Sheet
Executive Summary
Ventana Medical Systems: Nets $17.6 mil. from recently completed initial public offering of 2.1 mil. shares of common stock at $10 each. The offering includes 1.9 mil. shares sold by the company and 159,093 shares offered by selling stockholders. Ventana had anticipated an offering of 3 mil. shares for $14-16 each ("The Gray Sheet" June 24, p. 13) but scaled back the offering "due primarily to changes in the market conditions," the firm states. An underwriters over-allotment option for 307,500 additional shares is still outstanding...
You may also be interested in...
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.
Medicare Reimbursement For Part B Drugs Is 48% Above 340B Prices To Hospitals, MedPAC Finds
New study updates past commission analyses and highlights the significant margin between Medicare payments for drugs and the prices paid by 340B-eligible providers.
Drug Shortages, Inspections In Focus At US FDA Appropriations Hearing
Commissioner Robert Califf discussed the agency’s request for $12.3m to address shortages and legislation to require that manufacturers provide more detailed information about increased demand and supply chain vulnerabilities.